Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.37 - $1.88 $170,885 - $868,285
-461,854 Reduced 10.63%
3,884,285 $1.44 Million
Q1 2023

May 15, 2023

BUY
$1.75 - $2.7 $46,429 - $71,633
26,531 Added 0.61%
4,346,139 $7.91 Million
Q4 2022

Feb 10, 2023

BUY
$1.72 - $4.1 $486,128 - $1.16 Million
282,633 Added 7.0%
4,319,608 $8.94 Million
Q3 2022

Nov 14, 2022

BUY
$2.92 - $4.88 $3.88 Million - $6.48 Million
1,327,510 Added 49.0%
4,036,975 $12.2 Million
Q2 2022

Aug 12, 2022

BUY
$3.2 - $7.0 $8.07 Million - $17.7 Million
2,522,091 Added 1346.02%
2,709,465 $8.67 Million
Q1 2022

May 13, 2022

BUY
$6.45 - $14.67 $13,654 - $31,056
2,117 Added 1.14%
187,374 $1.21 Million
Q4 2021

Feb 14, 2022

BUY
$8.92 - $15.66 $537,492 - $943,624
60,257 Added 48.21%
185,257 $2.48 Million
Q3 2021

Nov 12, 2021

BUY
$11.81 - $20.0 $1.48 Million - $2.5 Million
125,000 New
125,000 $1.48 Million

Others Institutions Holding HLTH

About Cue Health Inc.


  • Ticker HLTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 148,152,992
  • Description
  • Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of ...
More about HLTH
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.